Close Menu

All the Vaccines

Moderna has reached a $1.5 billion deal with the US to provide it with 100 million doses of its candidate COVID-19 vaccine, Bloomberg reports. It adds that the US has made similar deals with Pfizer and Johnson & Johnson in a move to stockpile promising vaccine candidates

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novamax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.